# Phase 4 Pulmonary Disease, Chronic: 22 recruiting (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials in phase 4 for Pulmonary Disease, Chronic Obstructive that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Pulmonary Disease, Chronic Obstructive trials: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/pulmonary-disease-chronic-obstructive

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 14, 2026 | NCT07816835 | Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD | COPD Foundation | Phase 4 | Recruiting | COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Pulmonary Disease (COPD) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816835) |
| August 31, 2026 | NCT07795086 | Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD... | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Chronic Obstructive Pulmonary Disease With Exacerbation | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795086) |
| August 6, 2026 | NCT07749001 | Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab | Western University, Canada | Phase 4 | Not yet recruiting | COPD (Chronic Obstructive Pulmonary Disease) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749001) |
| May 14, 2026 | NCT07587658 | This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants... | Regeneron Pharmaceuticals | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease (COPD) | 754 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587658) |
| April 2, 2026 | NCT07508644 | RSV Vaccination to Reduce Recurrent AECOPD | Chinese University of Hong Kong | Phase 4 | Not yet recruiting | COPD, RSV | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07508644) |
| September 25, 2025 | NCT07192016 | 129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High... | Western University, Canada | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease (COPD) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07192016) |
| August 22, 2025 | NCT07135427 | Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency | University of Alabama at Birmingham | Phase 4 | Recruiting | Alpha 1-Antitrypsin, COPD, Antibody Deficiency | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07135427) |
| August 21, 2025 | NCT07133880 | Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators | University of Tennessee Graduate School of Medicine | Phase 4 | Recruiting | COPD (Chronic Obstructive Pulmonary Disease) | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07133880) |
| August 11, 2025 | NCT07114120 | Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Recruiting | Bronchiectasis, COPD | 214 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07114120) |
| July 20, 2025 | NCT07073950 | A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI... | AstraZeneca | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease, Hyperinflation | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07073950) |
| July 8, 2025 | NCT07053423 | A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive... | Sanofi | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07053423) |
| May 28, 2025 | NCT06991426 | Effects of CreaSafe® on Kidney, Muscle, and Cardiopulmonary Function in Athletes and COPD Patients | Federal University of São Paulo | Phase 4 | Not yet recruiting | Copd, Athletes | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06991426) |
| April 16, 2025 | NCT06929767 | Do Blood Tests Help to Decide Which Patients With Flares of Chronic Obstructive Pulmonary Disease (COPD) Need Antibiotics and Steroids? | Ottawa Hospital Research Institute | Phase 4 | Not yet recruiting | Chronic Obstructive Pulmonary Disease, COPD, Exacerbation of COPD, AECOPD, ECOPD | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06929767) |
| March 24, 2025 | NCT06892210 | Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) | Copenhagen Respiratory Research | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease (COPD) | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06892210) |
| February 13, 2025 | NCT06825728 | Metoprolol in Patients With HFrEF and COPD | Xiangya Hospital of Central South University | Phase 4 | Not yet recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF), COPD (Chronic Obstructive Pulmonary Disease) | 311 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06825728) |
| February 13, 2025 | NCT06825013 | Bronchodilators and Lung Mechanics During Exercise in COPD | Sponsor not shown (see the record) | Phase 4 | Recruiting | COPD | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06825013) |
| August 14, 2024 | NCT06552364 | Air Pollution and Inhaled Corticosteroids in COPD | University of British Columbia | Phase 4 | Not yet recruiting | COPD | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06552364) |
| March 28, 2024 | NCT06334575 | Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels | Sponsor not shown (see the record) | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06334575) |
| March 16, 2023 | NCT05772013 | Optimising Azithromycin Prevention Treatment in COPD to Reduce Exacerbations | Sponsor not shown (see the record) | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease | 1,311 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05772013) |
| January 30, 2023 | NCT05703919 | Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease | Central Denmark Region | Phase 4 | Recruiting | COPD Exacerbation, COPD Exacerbation Acute | 1,888 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05703919) |
| April 9, 2020 | NCT04339270 | Chronic Airway Disease, Mucus Rheology and Exacerbations | University Hospital, Montpellier | Phase 4 | Recruiting | Chronic Obstructive Pulmonary Disease | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04339270) |
| January 23, 2020 | NCT04238221 | Effect of add-on Doxofylline on Lung Function in Stable COPD | University of Milan | Phase 4 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04238221) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Western University, Canada | 2 |
| Central Denmark Region | 1 |
| Chinese University of Hong Kong | 1 |
| Federal University of São Paulo | 1 |
| Copenhagen Respiratory Research | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| University Hospital, Montpellier | 1 |
| University of British Columbia | 1 |
| Xiangya Hospital of Central South University | 1 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 1 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| University of Alabama at Birmingham | 1 |
| COPD Foundation | 1 |
| University of Tennessee Graduate School of Medicine | 1 |
| Ottawa Hospital Research Institute | 1 |
| University of Milan | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 5 |
| United Kingdom | 4 |
| Canada | 4 |
| Denmark | 3 |
| Germany | 3 |
| Brazil | 2 |
| China | 2 |
| France | 2 |
| Italy | 2 |
| Netherlands | 2 |
| Spain | 2 |
| Hong Kong | 1 |
| Argentina | 1 |
| Austria | 1 |
| Hungary | 1 |
| Japan | 1 |
| Poland | 1 |
| Saudi Arabia | 1 |
| Singapore | 1 |
| South Korea | 1 |
| Sweden | 1 |
| Switzerland | 1 |
| Taiwan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Manufacturers in the United States](https://specstream.ai/data/businesses/manufacturers/united-states)
- [Publishers in the United States](https://specstream.ai/data/businesses/publishers/united-states)
- [Veterans hospitals in the United States](https://specstream.ai/data/businesses/veterans-hospitals/united-states)
- [Book magazine distribution companies in the United States](https://specstream.ai/data/businesses/book-magazine-distribution-companies/united-states)
- [Employment agencies in the United States](https://specstream.ai/data/businesses/employment-agencies/united-states)
- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
